MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:MDA - CA55293N1096 - Common Stock
25.69 CAD
-0.02 (-0.08%)
MDA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 11 industry peers in the Aerospace & Defense industry. MDA has an excellent profitability rating, but there are some minor concerns on its financial health. MDA is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, MDA could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
In the past year MDA was profitable.
In the past year MDA had a positive cash flow from operations.
Of the past 5 years MDA 4 years were profitable.
In the past 5 years MDA always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 3.15%, MDA belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
MDA's Return On Equity of 8.24% is amongst the best of the industry. MDA outperforms 90.91% of its industry peers.
With a Return On Invested Capital value of 5.12%, MDA perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
MDA had an Average Return On Invested Capital over the past 3 years of 3.99%. This is below the industry average of 8.45%.
The 3 year average ROIC (3.99%) for MDA is below the current ROIC(5.12%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 8.24% | ||
| ROIC | 5.12% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
MDA has a Profit Margin of 7.40%. This is amongst the best in the industry. MDA outperforms 90.91% of its industry peers.
In the last couple of years the Profit Margin of MDA has grown nicely.
Looking at the Operating Margin, with a value of 9.86%, MDA is in line with its industry, outperforming 45.45% of the companies in the same industry.
In the last couple of years the Operating Margin of MDA has grown nicely.
Looking at the Gross Margin, with a value of 24.62%, MDA is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
In the last couple of years the Gross Margin of MDA has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.86% | ||
| PM (TTM) | 7.4% | ||
| GM | 24.62% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MDA is destroying value.
Compared to 1 year ago, MDA has more shares outstanding
The debt/assets ratio for MDA has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.33, we must say that MDA is in the distress zone and has some risk of bankruptcy.
MDA has a better Altman-Z score (1.33) than 81.82% of its industry peers.
MDA has a debt to FCF ratio of 0.92. This is a very positive value and a sign of high solvency as it would only need 0.92 years to pay back of all of its debts.
MDA has a Debt to FCF ratio of 0.92. This is amongst the best in the industry. MDA outperforms 100.00% of its industry peers.
MDA has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.31, MDA belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.92 | ||
| Altman-Z | 1.33 |
ROIC/WACC0.56
WACC9.11%
2.3 Liquidity
MDA has a Current Ratio of 0.55. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of MDA (0.55) is worse than 81.82% of its industry peers.
A Quick Ratio of 0.54 indicates that MDA may have some problems paying its short term obligations.
The Quick ratio of MDA (0.54) is better than 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.54 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 98.25% over the past year.
The Earnings Per Share has been growing by 185.75% on average over the past years. This is a very strong growth
The Revenue has grown by 57.77% in the past year. This is a very strong growth!
MDA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.32% yearly.
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
3.2 Future
The Earnings Per Share is expected to grow by 35.31% on average over the next years. This is a very strong growth
Based on estimates for the next years, MDA will show a very strong growth in Revenue. The Revenue will grow by 23.78% on average per year.
EPS Next Y106.33%
EPS Next 2Y49.18%
EPS Next 3Y35.31%
EPS Next 5YN/A
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.78%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 22.73, MDA is valued on the expensive side.
72.73% of the companies in the same industry are more expensive than MDA, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.55. MDA is around the same levels.
A Price/Forward Earnings ratio of 16.49 indicates a correct valuation of MDA.
63.64% of the companies in the same industry are more expensive than MDA, based on the Price/Forward Earnings ratio.
MDA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.78.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.73 | ||
| Fwd PE | 16.49 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, MDA is valued a bit cheaper than 63.64% of the companies in the same industry.
72.73% of the companies in the same industry are more expensive than MDA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.96 | ||
| EV/EBITDA | 12.97 |
4.3 Compensation for Growth
MDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of MDA may justify a higher PE ratio.
A more expensive valuation may be justified as MDA's earnings are expected to grow with 35.31% in the coming years.
PEG (NY)0.21
PEG (5Y)N/A
EPS Next 2Y49.18%
EPS Next 3Y35.31%
5. Dividend
5.1 Amount
No dividends for MDA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX:MDA (12/15/2025, 7:00:00 PM)
25.69
-0.02 (-0.08%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners38.36%
Inst Owner ChangeN/A
Ins Owners1.17%
Ins Owner ChangeN/A
Market Cap3.25B
Revenue(TTM)1.48B
Net Income(TTM)109.60M
Analysts78.33
Price Target39.46 (53.6%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.07%
Min EPS beat(2)-40.3%
Max EPS beat(2)22.16%
EPS beat(4)3
Avg EPS beat(4)5.53%
Min EPS beat(4)-40.3%
Max EPS beat(4)22.16%
EPS beat(8)6
Avg EPS beat(8)21.97%
EPS beat(12)10
Avg EPS beat(12)31.49%
EPS beat(16)13
Avg EPS beat(16)66.41%
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)0.35%
Revenue beat(4)3
Avg Revenue beat(4)3.66%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)2.65%
Revenue beat(12)9
Avg Revenue beat(12)2.56%
Revenue beat(16)11
Avg Revenue beat(16)1.78%
PT rev (1m)-11.19%
PT rev (3m)-9.28%
EPS NQ rev (1m)0.85%
EPS NQ rev (3m)-3.72%
EPS NY rev (1m)-0.69%
EPS NY rev (3m)-2.72%
Revenue NQ rev (1m)-0.89%
Revenue NQ rev (3m)-0.89%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)-0.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.73 | ||
| Fwd PE | 16.49 | ||
| P/S | 2.19 | ||
| P/FCF | 6.96 | ||
| P/OCF | 4.41 | ||
| P/B | 2.44 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.97 |
EPS(TTM)1.13
EY4.4%
EPS(NY)1.56
Fwd EY6.06%
FCF(TTM)3.69
FCFY14.37%
OCF(TTM)5.82
OCFY22.67%
SpS11.72
BVpS10.52
TBVpS-2.82
PEG (NY)0.21
PEG (5Y)N/A
Graham Number16.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 8.24% | ||
| ROCE | 7.1% | ||
| ROIC | 5.12% | ||
| ROICexc | 5.66% | ||
| ROICexgc | 60.4% | ||
| OM | 9.86% | ||
| PM (TTM) | 7.4% | ||
| GM | 24.62% | ||
| FCFM | 31.5% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexgc growth 3Y59.28%
ROICexgc growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.92 | ||
| Debt/EBITDA | 1.55 | ||
| Cap/Depr | 226.87% | ||
| Cap/Sales | 18.19% | ||
| Interest Coverage | 9.36 | ||
| Cash Conversion | 277.94% | ||
| Profit Quality | 425.55% | ||
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.54 | ||
| Altman-Z | 1.33 |
F-Score6
WACC9.11%
ROIC/WACC0.56
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y106.33%
EPS Next 2Y49.18%
EPS Next 3Y35.31%
EPS Next 5YN/A
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.78%
Revenue Next 5YN/A
EBIT growth 1Y64.41%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year182.28%
EBIT Next 3Y51.82%
EBIT Next 5YN/A
FCF growth 1Y631.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y674.42%
OCF growth 3Y124.48%
OCF growth 5YN/A
MDA SPACE LTD / MDA.CA FAQ
What is the fundamental rating for MDA stock?
ChartMill assigns a fundamental rating of 6 / 10 to MDA.CA.
What is the valuation status for MDA stock?
ChartMill assigns a valuation rating of 6 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Fairly Valued.
What is the profitability of MDA stock?
MDA SPACE LTD (MDA.CA) has a profitability rating of 7 / 10.
What is the valuation of MDA SPACE LTD based on its PE and PB ratios?
The Price/Earnings (PE) ratio for MDA SPACE LTD (MDA.CA) is 22.73 and the Price/Book (PB) ratio is 2.44.